Felix Chua

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

Toby M. Maher, Veronica A Tudor, Peter Saunders et al. · The Lancet Respiratory Medicine · 2022 · 271 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 239 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial

Dina Visca, Letizia Mori, Vicky Tsipouri et al. · The Lancet Respiratory Medicine · 2018 · 228 citations · Full text

Medicine, Internal Medicine, Respiratory Therapy +12

Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study

Ibrahim Abubakar, Francis Drobniewski, Jo Southern et al. · The Lancet Infectious Diseases · 2018 · 184 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +15

Passive Stiffness of Myocardium From Congenital Heart Disease and Implications for Diastole

Rajiv Chaturvedi, Todd J. Herron, Robert Simmons et al. · Circulation · 2010 · 162 citations

Natural Sciences, Cardiology, Physiology +17